Brown Advisory, an investment management company, released its “Brown Advisory Mid-Cap Growth Strategy” third-quarter 2025 ...

Cardinal Health stock is being upgraded to a buy rating, from my prior hold rating last year, agreeing with the SA analyst consensus today. Bullish drivers include recent revenue/earnings growth, ...

Feb 1 (Reuters) - Cardinal Health (CAH.N), opens new tab lowered the full-year profit forecast for its medical segment on Thursday, taking the shine off the company's upbeat second-quarter results and ...

Looking back on healthcare providers & services stocks’ Q3 earnings, we examine this quarter’s best and worst performers, ...

Cardinal Health (CAH) closed at $150.27 in the latest trading session, marking a -1.29% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.47% for the day.

The Cordis medical device business that Cardinal Health bought for $1.9 billion is proving to be a millstone for the company. Cordis, a former Johnson & Johnson subsidiary, ran into a raft of ...

Cardinal Health, which manufactures and distributes medical and laboratory products, has entered into a definitive agreement to acquire Integrated Oncology Network, a physician-led independent ...

Cardinal Health shared its plans to open a new distribution center in Walton Hills, Ohio, supporting its U.S. Medical Products and Distribution business. The facility will integrate new technology ...

The COVID-19 pandemic exposed critical flaws in hospital supply chains for vital equipment like ventilators and personal protective gear. Many health systems struggled with shortages and often ...

DUBLIN, Ohio, Feb. 9, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced it will leverage the Kinaxis® RapidResponse® platform to increase medical product visibility and supply chain ...

Drug distributor Cardinal Health Inc said on Friday it would sell its Cordis medical device business to private equity firm Hellman & Friedman in a deal valued at about $1 billion. Updates with ...

Cardinal Health has no plans to sell its medical supply division despite ongoing struggles, this time due to inflation, CEO Mike Kaufmann said. Here's how Cardinal ...